Towards a universal understanding of post COVID-19 condition

Bulletin of the World Health Organization
Volume 99(12);  2021 Dec 1
https://www.ncbi.nlm.nih.gov/pmc/issues/394921/

 

Perspectives
Towards a universal understanding of post COVID-19 condition
Janet V Diaz, Margaret Herridge, Silvia Bertagnolio, Hannah E Davis, Tarun Dua, Charu Kaushic, John C Marshall, Maria del Rosario Pérez, Nathalie Strub-Wourgaft, Joan B Soriano
Bull World Health Organ. 2021 Dec 1; 99(12): 901–903. Published online 2021 Oct 5. doi: 10.2471/BLT.21.286249
PMCID: PMC8640686

Addressing production gaps for vaccines in African countries

Bulletin of the World Health Organization
Volume 99(12);  2021 Dec 1
https://www.ncbi.nlm.nih.gov/pmc/issues/394921/

 

Addressing production gaps for vaccines in African countries
Anna Mia Ekström, Göran Tomson, Rhoda K Wanyenze, Zulfiqar A Bhutta, Catherine Kyobutungi, Agnes Binagwaho, Ole Petter Ottersen
Bull World Health Organ. 2021 Dec 1; 99(12): 910–912. Published online 2021 Nov 17. doi: 10.2471/BLT.21.287381
PMCID: PMC8640685

A fair allocation approach to the ethics of scarce resources in the context of a pandemic: The need to prioritize the worst-off in the Philippines

Developing World Bioethics
Volume 21, Issue 4 Pages: 149-238 December 2021
https://onlinelibrary.wiley.com/toc/14718847/current

 

COUNTRY REPORTS
Free Access
A fair allocation approach to the ethics of scarce resources in the context of a pandemic: The need to prioritize the worst-off in the Philippines
Leonardo De Castro, Alexander Atrio Lopez, Geohari Hamoy, Kriedge Chlare Alba, Joshua Cedric Gundayao
Pages: 153-172
First Published: 23 September 2020

Seeking an ethical theory for the COVID-19 pandemic outbreak with special reference to Bangladesh’s law and policy

Developing World Bioethics
Volume 21, Issue 4 Pages: 149-238 December 2021
https://onlinelibrary.wiley.com/toc/14718847/current

 

Free Access
Seeking an ethical theory for the COVID-19 pandemic outbreak with special reference to Bangladesh’s law and policy
A S M Anwarullah Bhuiyan
Pages: 173-186
First Published: 06 September 2020

COVID-19: What have we learned? What are the public health challenges?

The European Journal of Public Health
Volume 31, Issue Supplement_4, November 2021 Supplement
https://academic.oup.com/eurpub/issue/31/5

 

COVID-19: What have we learned? What are the public health challenges?
Guest Editors: Dineke Zeegers Paget, Iveta Nagyova, Peter Allebeck
Supplement papers
COVID-19: What have we learned? What are the public health challenges?
Dineke Zeegers Paget, Peter Allebeck, Iveta Nagyova
European Journal of Public Health, Volume 31, Issue Supplement_4, November 2021, Pages iv1–iv2, https://doi.org/10.1093/eurpub/ckab150

Reducing the impact of the coronavirus on disadvantaged migrants and ethnic minorities

The European Journal of Public Health
Volume 31, Issue Supplement_4, November 2021 Supplement
https://academic.oup.com/eurpub/issue/31/5

 

Reducing the impact of the coronavirus on disadvantaged migrants and ethnic minorities
Bernadette N Kumar, Sally Hargreaves, Charles Agyemang, Rosemary A James, Karl Blanchet
European Journal of Public Health, Volume 31, Issue Supplement_4, November 2021, Pages iv9–iv13, https://doi.org/10.1093/eurpub/ckab151

Ethical implications of COVID-19: vulnerabilities in a global perspective

The European Journal of Public Health
Volume 31, Issue Supplement_4, November 2021 Supplement
https://academic.oup.com/eurpub/issue/31/5

 

Ethical implications of COVID-19: vulnerabilities in a global perspective
Els Maeckelberghe
European Journal of Public Health, Volume 31, Issue Supplement_4, November 2021, Pages iv50–iv53, https://doi.org/10.1093/eurpub/ckab158

The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment

The European Journal of Public Health
Volume 31, Issue Supplement_4, November 2021 Supplement
https://academic.oup.com/eurpub/issue/31/5

 

The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment
Elena Petelos, Dimitra Lingri, Jinane Ghattas, Silvia M A A Evers, Dineke Zeegers Paget
European Journal of Public Health, Volume 31, Issue Supplement_4, November 2021, Pages iv54–iv58, https://doi.org/10.1093/eurpub/ckab160

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/localisation-and-local-humanitarian-action/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

‘When you welcome well, you vaccinate well’: a qualitative study on improving vaccination coverage in urban settings in Conakry, Republic of Guinea

International Health
Volume 13, Issue 6, November 2021
https://academic.oup.com/inthealth/issue/13/6

 

ORIGINAL ARTICLES
‘When you welcome well, you vaccinate well’: a qualitative study on improving vaccination coverage in urban settings in Conakry, Republic of Guinea
Julita Gil Cuesta, Katherine Whitehouse, Salimou Kaba, Kassi Nanan-N’Zeth, Benoit Haba
International Health, Volume 13, Issue 6, November 2021, Pages 586–593, https://doi.org/10.1093/inthealth/ihz097

Taking stock of global immunisation coverage progress: the gains, the losses and the journey ahead

International Health
Volume 13, Issue 6, November 2021
https://academic.oup.com/inthealth/issue/13/6

 

COMMENTARY
Taking stock of global immunisation coverage progress: the gains, the losses and the journey ahead
C A Nnaji, A J Owoyemi, U A Amaechi, A B Wiyeh, D E Ndwandwe
International Health, Volume 13, Issue 6, November 2021, Pages 653–657, https://doi.org/10.1093/inthealth/ihz120

Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers

International Journal of Infectious Diseases
December 2021 Volume 113 p1-366
https://www.ijidonline.com/current

 

Coronavirus (COVID-19) Collection
Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers
Theodore W. Heyming, Diane Nugent, Aprille Tongol,…Kellie Bacon, Bryan Lara, Terence Sanger
Published online: September 30, 2021
p1-6

The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries

International Journal of Infectious Diseases
December 2021 Volume 113 p1-366
https://www.ijidonline.com/current

 

The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries
Banda A. Khalifa, Enoch J. Abbey, Samuel K. Ayeh,…Emmanuella L. Salia, Oluwatobi Lasisi, Petros C. Karakousis
Published online: September 18, 2021

Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre

International Journal of Infectious Diseases
December 2021 Volume 113 p1-366
https://www.ijidonline.com/current

 

Measuring the impact of a single dose of ChAdOx1 nCoV-19 (recombinant) coronavirus vaccine on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre
Anuja Desai, Parth Desai, Jigar Mehta,…Vivek Nanda, Parin Mehta, Adit Desai
Published online: October 20, 2021
p282-287

Parent and Peer Norms are Unique Correlates of COVID-19 Vaccine Intentions in a Diverse Sample of U.S. Adolescents

Journal of Adolescent Health
December 2021 Volume 69 Issue 6 p861-1054
https://www.jahonline.org/current

 

Original Articles
Parent and Peer Norms are Unique Correlates of COVID-19 Vaccine Intentions in a Diverse Sample of U.S. Adolescents
Adam A. Rogers, Rachel E. Cook, Julie A. Button
Published online: September 22, 2021
p910-916

COVID-19 Vaccination and Intention to Vaccinate Among a Sample of College Students in New Jersey

Journal of Community Health
Volume 46, issue 6, December 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-6

 

Original Paper
COVID-19 Vaccination and Intention to Vaccinate Among a Sample of College Students in New Jersey
Authors (first, second and last of 5)
Aleksandar Kecojevic, Corey H. Basch, Nicole K. Davi
Published: 27 April 2021
Pages: 1059 – 1068

COVID-19 Vaccine Hesitancy and Its Determinants Among Adults with a History of Tobacco or Marijuana Use

Journal of Community Health
Volume 46, issue 6, December 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-6

 

COVID-19 Vaccine Hesitancy and Its Determinants Among Adults with a History of Tobacco or Marijuana Use
Authors Yong Yang, Aram Dobalian, Kenneth D. Ward
Content type: Original Paper
Published: 06 May 2021
Pages: 1090 – 1098

Primary Care Interventions to Address COVID-19 Vaccine Hesitancy Among Israel Defense Forces Soldiers

Journal of Community Health
Volume 46, issue 6, December 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-6

 

Primary Care Interventions to Address COVID-19 Vaccine Hesitancy Among Israel Defense Forces Soldiers
Authors (first, second and last of 4) Tomer Talmy, Bar Cohen, Yossi Ben Michael
Content type: Original Paper
Published: 14 May 2021
Pages: 1155 – 1160

Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community

Journal of Community Health
Volume 46, issue 6, December 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-6

 

Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community
Authors (first, second and last of 5) Ellie R. Carmody, Devon Zander, Arthur L. Caplan
Content type: Original Paper
Published: 17 May 2021
Pages: 1161 – 1169

Human Papillomavirus Vaccination and Pap Smear Rates Among Burmese Refugee Girls in a Healthcare System in Omaha, Nebraska

Journal of Community Health
Volume 46, issue 6, December 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-6

 

Human Papillomavirus Vaccination and Pap Smear Rates Among Burmese Refugee Girls in a Healthcare System in Omaha, Nebraska
Authors (first, second and last of 4) Dorothy Xuanxian Kenny, Katherine Hsueh, John Joseph Coté
Content type: Original Paper
Published: 21 May 2021
Pages: 1170 – 1176

The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers

Journal of Community Health
Volume 46, issue 6, December 2021
https://link.springer.com/journal/10900/volumes-and-issues/46-6

 

The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers
Authors (first, second and last of 4) Nirbachita Biswas, Toheeb Mustapha, James H. Price
Content type: Review
Published: 20 April 2021
Pages: 1244 – 1251

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

The Lancet
Dec 04, 2021 Volume 398 Number 10316 p2051-2124
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
Milena Falcaro, et al.

How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic

The Lancet
Dec 04, 2021 Volume 398 Number 10316 p2051-2124
https://www.thelancet.com/journals/lancet/issue/current

 

Health Policy
How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic
Sudhvir Singh, et al.
Published: November 08, 2021
Summary
Understanding the spread of SARS-CoV-2, how and when evidence emerged, and the timing of local, national, regional, and global responses is essential to establish how an outbreak became a pandemic and to prepare for future health threats. With that aim, the Independent Panel for Pandemic Preparedness and Response has developed a chronology of events, actions, and recommendations, from December, 2019, when the first cases of COVID-19 were identified in China, to the end of March, 2020, by which time the outbreak had spread extensively worldwide and had been characterised as a pandemic. Datapoints are based on two literature reviews, WHO documents and correspondence, submissions to the Panel, and an expert verification process. The retrospective analysis of the chronology shows a dedicated initial response by WHO and some national governments, but also aspects of the response that could have been quicker, including outbreak notifications under the International Health Regulations (IHR), presumption and confirmation of human-to-human transmission of SARS-CoV-2, declaration of a Public Health Emergency of International Concern, and, most importantly, the public health response of many national governments. The chronology also shows that some countries, largely those with previous experience with similar outbreaks, reacted quickly, even ahead of WHO alerts, and were more successful in initially containing the virus. Mapping actions against IHR obligations, the chronology shows where efficiency and accountability could be improved at local, national, and international levels to more quickly alert and contain health threats in the future. In particular, these improvements include necessary reforms to international law and governance for pandemic preparedness and response, including the IHR and a potential framework convention on pandemic preparedness and response.

Blockchain applications in health care for COVID-19 and beyond: a systematic review

Lancet Digital Health
Dec 2021 Volume 3 Number 12 e751-e829
https://www.thelancet.com/journals/landig/issue/current

 

Review
Blockchain applications in health care for COVID-19 and beyond: a systematic review
Wei Yan Ng, et al.
Summary
The COVID-19 pandemic has had a substantial and global impact on health care, and has greatly accelerated the adoption of digital technology. One of these emerging digital technologies, blockchain, has unique characteristics (eg, immutability, decentralisation, and transparency) that can be useful in multiple domains (eg, management of electronic medical records and access rights, and mobile health). We conducted a systematic review of COVID-19-related and non-COVID-19-related applications of blockchain in health care. We identified relevant reports published in MEDLINE, SpringerLink, Institute of Electrical and Electronics Engineers Xplore, ScienceDirect, arXiv, and Google Scholar up to July 29, 2021. Articles that included both clinical and technical designs, with or without prototype development, were included. A total of 85 375 articles were evaluated, with 415 full length reports (37 related to COVID-19 and 378 not related to COVID-19) eventually included in the final analysis. The main COVID-19-related applications reported were pandemic control and surveillance, immunity or vaccine passport monitoring, and contact tracing. The top three non-COVID-19-related applications were management of electronic medical records, internet of things (eg, remote monitoring or mobile health), and supply chain monitoring. Most reports detailed technical performance of the blockchain prototype platforms (277 [66·7%] of 415), whereas nine (2·2%) studies showed real-world clinical application and adoption. The remaining studies (129 [31·1%] of 415) were themselves of a technical design only. The most common platforms used were Ethereum and Hyperledger. Blockchain technology has numerous potential COVID-19-related and non-COVID-19-related applications in health care. However, much of the current research remains at the technical stage, with few providing actual clinical applications, highlighting the need to translate foundational blockchain technology into clinical use.

Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data

Lancet Global Health
Dec 2021 Volume 9 Number 12 e1623-e1769
https://www.thelancet.com/journals/langlo/issue/current

 

Articles
Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data
Tapfumanei Mashe, et al. on behalf of the COVID-19 Genomics UK Consortium, and the SARS-CoV-2 Research Group

Progress in reaching unvaccinated (zero-dose) children in India, 1992–2016: a multilevel, geospatial analysis of repeated cross-sectional surveys

Lancet Global Health
Dec 2021 Volume 9 Number 12 e1623-e1769
https://www.thelancet.com/journals/langlo/issue/current

 

Articles
Progress in reaching unvaccinated (zero-dose) children in India, 1992–2016: a multilevel, geospatial analysis of repeated cross-sectional surveys
Mira Johri, Sunil Rajpal, S V Subramanian
Summary
Background
Reaching zero-dose children (infants who receive no routine vaccinations) is a global strategic priority. We studied zero-dose children in India over 24 years to clarify aggregate trends and the contribution of large-scale social, economic, and geographical inequalities to these.
Methods
We did a multilevel, geospatial analysis of repeated cross-sectional surveys of all four rounds (1992–2016) of India’s National Family Health Survey to study the prevalence, distribution, and drivers of zero-dose (no first dose of diphtheria, tetanus, and pertussis) vaccination status. We included all children born to participating women who were aged 12–23 months at the time of the survey, as this is the standard age at which immunisation data are assessed. Children who died before the survey and those missing data on key outcomes or correlates were excluded. The outcome was child zero-dose vaccination status. We also compared the prevalence of nutritional deficits among zero-dose versus vaccinated children. For the most recent survey, we produced geospatial estimates identifying the prevalence of zero-dose children across states and districts and used these to project head count.
Findings
We examined 393 167 children for eligibility. 72 848 children were included in the final analytic data set. The proportion of zero-dose children in India declined from 33·4% (95% CI 32·5–34·2) in 1992 to 10·1% (9·8–10·4) in 2016. Progress notwithstanding, in 2016, zero-dose children remained concentrated among disadvantaged groups (prevalence in the bottom wealth quintile 15·3%, 95% CI 14·6–16·0; prevalence among mothers with no education 16·8%, 16·1–17·4). Compared with vaccinated children, zero-dose children were more likely to suffer from malnutrition in all survey rounds (prevalence of severe stunting in 1992: zero dose 41·3%, 95% CI 39·2–43·8 vs vaccinated 28·5%, 27·2–29·7; 2016: zero dose 24·9%, 23·6–26·2 vs vaccinated 18·7%, 18·3–19·1). In 2016, there were an estimated 2·88 (95% CI 2·86–2·89) million zero-dose children in India, concentrated in less developed states and districts and several urban areas.
Interpretation
Over a 24-year period in India, child zero-dose status was shaped by large-scale social inequalities and remained a consistent marker of generalised vulnerability. Interventions that address this cycle of intergenerational inequities should be prioritised.

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Lancet Infectious Diseases
Dec 2021 Volume 21 Number 12 p1613-1758, e363-e406
https://www.thelancet.com/journals/laninf/issue/current

 

Articles
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
Bihua Han, et al.

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial

Lancet Infectious Diseases
Dec 2021 Volume 21 Number 12 p1613-1758, e363-e406
https://www.thelancet.com/journals/laninf/issue/current

 

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
Shipo Wu, et al.

Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial

Lancet Infectious Diseases
Dec 2021 Volume 21 Number 12 p1613-1758, e363-e406
https://www.thelancet.com/journals/laninf/issue/current

 

Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial
Paul R Chapman, et al.

Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review

Lancet Infectious Diseases
Dec 2021 Volume 21 Number 12 p1613-1758, e363-e406
https://www.thelancet.com/journals/laninf/issue/current

 

Review
Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review
Anna Deal, et al. in collaboration with the European Society of Clinical Microbiology and Infectious Diseases Study Group for Infections in Travellers and Migrants (ESGITM)

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan

Lancet Respiratory Medicine
Dec 2021 Volume 9 Number 12 p1343-1478, e110-e122
https://www.thelancet.com/journals/lanres/issue/current

 

Articles
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
Szu-Min Hsieh, et al.

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study

Lancet Respiratory Medicine
Dec 2021 Volume 9 Number 12 p1343-1478, e110-e122
https://www.thelancet.com/journals/lanres/issue/current

 

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
Utkarsh Agrawal, et al.